Many are eagerly awaiting approval of certain drugs whether it be to cure a patient or to realize the research put into the development of the drug. Would a speedier drug approval process ultimately help or hinder our healthcare system? Join Dr. Larry Kaskel interviewing Peter Pitts, co-founder of the Center for Medicine in the Public Interest.